Image-01 (Labetalol 01)
Labetalol Hydrochloride Injection, Solution
Product Images NDC 68083-111
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 68083-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 2 (Labetalol 02)
This is a description of a medication containing labetalol hydrochloride USP, an anhydrous dextrose, and preservatives. The pH of the medication is adjusted using citric acid monohydrate and sodium hydroxide. There are specific instructions for dosage and administration in the package insert. The medication should be stored at a temperature between 20°C to 25°C and protected from freezing and light. It is manufactured by Gland Pharma Limited in Hyderabad, India. The provided text also includes a lot number and barcode.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
